These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6255132)

  • 21. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.
    Borbe HO; Zierenberg O
    Pharmacopsychiatry; 1985 Sep; 18(5):314-9. PubMed ID: 2996040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration].
    Wei HB; Niu XY
    Yao Xue Xue Bao; 1990; 25(12):881-5. PubMed ID: 1966571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of chronic treatment with antidepressant neuroleptics on the central serotonin system.
    Antkiewicz-Michaluk L
    Pol J Pharmacol Pharm; 1986; 38(4):359-70. PubMed ID: 3774629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
    Klimek V; Zak-Knapik J; Mackowiak M
    J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical effects in rats after acute and long-term treatment with clovoxamine.
    Bradford LD; Tulp MT; Schipper J
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):188-202. PubMed ID: 2820327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics].
    Vasar EE; Nurk AM; Maĭmets MO; Allikmets LKh
    Biull Eksp Biol Med; 1985 Jan; 99(1):72-4. PubMed ID: 2857100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Eneroth P
    Adv Biochem Psychopharmacol; 1982; 31():91-107. PubMed ID: 7080902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour.
    Stolz JF; Marsden CA; Middlemiss DN
    Psychopharmacology (Berl); 1983; 80(2):150-5. PubMed ID: 6410444
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of the effects of 4 psychiatric treatments on rat brain beta 5HT2 receptors].
    Zhou D
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):207-9, 251-2. PubMed ID: 1659512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.